FDA/CDC

List of COVID-19 high-risk comorbidities expanded


 

The list of medical comorbidities associated with high risk for severe COVID-19 now includes moderate to severe asthma, diabetes, and substance use disorders, according to the Centers for Disease Control and Prevention.

Comorbidities associated with high risk for severe COVID-19

The CDC’s latest list consists of 17 conditions or groups of related conditions that may increase patients’ risk of developing severe outcomes of COVID-19, the CDC said on a web page intended for the general public.

On a separate page, the CDC defines severe outcomes “as hospitalization, admission to the intensive care unit, intubation or mechanical ventilation, or death.”

Asthma is included in the newly expanded list with other chronic lung diseases such as chronic obstructive pulmonary disease and cystic fibrosis; the list’s heart disease entry covers coronary artery disease, heart failure, cardiomyopathies, and hypertension, the CDC said.

Recommended Reading

Vitamin D may protect against COVID-19, especially in Black patients
MDedge Hematology and Oncology
In U.S., lockdowns added 2 pounds per month
MDedge Hematology and Oncology
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
MDedge Hematology and Oncology
COVID vaccines could lose their punch within a year, experts say
MDedge Hematology and Oncology
Vaccine mismatch: What to do after dose 1 when plans change
MDedge Hematology and Oncology
CDC adds new medical conditions to COVID-19 high-risk list
MDedge Hematology and Oncology
COVID-19 in 2020: Deaths and disparities
MDedge Hematology and Oncology
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
MDedge Hematology and Oncology
Excess deaths jump 23% in U.S. in 2020, mostly because of COVID-19
MDedge Hematology and Oncology
Study suggests no added risk of blood clots in COVID-19 outpatients
MDedge Hematology and Oncology